- Home
- OVLY vs LRMR Comparison
OVLY vs LRMR Comparison
Compare OVLY & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVLY
- LRMR
- Stock Information
- Founded
- OVLY 1990
- LRMR N/A
- Country
- OVLY United States
- LRMR United States
- Employees
- OVLY N/A
- LRMR N/A
- Industry
- OVLY Major Banks
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- OVLY Finance
- LRMR Health Care
- Exchange
- OVLY Nasdaq
- LRMR Nasdaq
- Market Cap
- OVLY 218.4M
- LRMR 204.9M
- IPO Year
- OVLY N/A
- LRMR N/A
- Fundamental
- Price
- OVLY $28.36
- LRMR $3.27
- Analyst Decision
- OVLY
- LRMR Strong Buy
- Analyst Count
- OVLY 0
- LRMR 7
- Target Price
- OVLY N/A
- LRMR $17.86
- AVG Volume (30 Days)
- OVLY 18.7K
- LRMR 1.1M
- Earning Date
- OVLY 07-22-2025
- LRMR 08-06-2025
- Dividend Yield
- OVLY 2.12%
- LRMR N/A
- EPS Growth
- OVLY N/A
- LRMR N/A
- EPS
- OVLY 2.97
- LRMR N/A
- Revenue
- OVLY $78,869,000.00
- LRMR N/A
- Revenue This Year
- OVLY N/A
- LRMR N/A
- Revenue Next Year
- OVLY N/A
- LRMR N/A
- P/E Ratio
- OVLY $9.64
- LRMR N/A
- Revenue Growth
- OVLY 0.39
- LRMR N/A
- 52 Week Low
- OVLY $22.70
- LRMR $1.61
- 52 Week High
- OVLY $32.24
- LRMR $11.20
- Technical
- Relative Strength Index (RSI)
- OVLY 65.56
- LRMR 64.72
- Support Level
- OVLY $27.46
- LRMR $3.30
- Resistance Level
- OVLY $29.17
- LRMR $3.68
- Average True Range (ATR)
- OVLY 0.60
- LRMR 0.25
- MACD
- OVLY 0.10
- LRMR 0.02
- Stochastic Oscillator
- OVLY 73.96
- LRMR 72.41
About OVLY Oak Valley Bancorp (CA)
Oak Valley Bancorp is a bank holding company that operates through Oak Valley Community Bank (the Bank). The Bank offers a complement of business checking and savings accounts for its business customers. The Bank also offers commercial and real estate loans, as well as lines of credit. In addition, the bank provides other services for both individuals and businesses including online banking, remote deposit capture, mobile banking, merchant services, night depository, extended hours, wire transfer of funds, note collection, and automated teller machines in a national network. Its primary source of revenue is net interest income.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.